The Risk of Thrombotic Events in Anetoderma Affecting Young Patients

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.10.1111/j.1538-7836.2006.01753.x16420554Search in Google Scholar

2. Thornsberry LA, LoSicco K, English JC 3rd. The skin and hypercoagulable states. J Am Acad Dermatol. 2013;69:450-462.10.1016/j.jaad.2013.01.04323582572Search in Google Scholar

3. Hodak E, Feureman H, Molad Y, et al. Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Lupus. 2003;12:564-568.10.1191/0961203303lu403oa12892400Search in Google Scholar

4. Hodak E, David M. Primary anetoderma and antiphospholipid antibodies – review of the literature. Clin Rev Allergy Immunol. 2007;32:162-166.10.1007/s12016-007-0011-117916987Search in Google Scholar

5. Venhoff N, Miehle N, Juttner E, et al. Clinical images: anetoderma in systemic lupus erythematosus with antiphospholipid antibodies. Arthritis Rheum. 2005;52:2228.10.1002/art.2106315986337Search in Google Scholar

6. Bilen N, Bayamgurler D, Sikar A, et al. Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus. Lupus. 2003;12:714-716.10.1191/0961203303lu431cr14514137Search in Google Scholar

7. Sabio JM, Tercedor J, Massare E, et al. Anetoderma associated with systemic lupus erythematosus and antiphospholipid antibodies. Lupus. 2004;13:826-827.10.1191/0961203303lu1058xx15540519Search in Google Scholar

8. Wollina U, Mühle D, Lotti T, et al. Anetoderma Schweninger-Buzzi: Two Case Reports. Open Access Maced J Med Sci. 2019;7:3093-3095.10.3889/oamjms.2019.560691078931850130Search in Google Scholar

9. Hofer T, Goldenberger D, Itin PH. Anetoderma and borreliosis: is there a pathogenetic relationship? Eur J Dermatol. 2003;13:399-401.Search in Google Scholar

10. Emer J, Roberts D, Sidhu H, et al. Generalized Anetoderma after Intravenous Penicillin Therapy for Secondary Syphilis in an HIV Patient. J Clin Aesthet Dermatol. 2013;6:23-28.Search in Google Scholar

11. Criado PR, Rivitti EA, Vasconcellos C, et al. Manifestações cutâneas das trombofilias. An Bras Dermatol. 2008;83:491-506.10.1590/S0365-05962008000600002Search in Google Scholar

12. Genta MP, Abreu MAMM, Nai GA. Anetoderma: an alert for antiphospholipid antibody syndrome. An Bras Dermatol. 2020;95:123-125.10.1016/j.abd.2019.04.010705888231987491Search in Google Scholar

13. Sparsa A, Piette JC, Wechsler B, et al. Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol. 2003;49:1008-1012.10.1016/S0190-9622(03)02110-8Search in Google Scholar

14. Romaní J, Pérez F, Llobet M, et al. Anetoderma associated with antiphospholipid antibodies: case report and review of the literature. J Eur Acad Dermatol Venereol. 2001;15:175-178.10.1046/j.1468-3083.2001.00255.x11495531Search in Google Scholar